Drug Shortage Report for ACT BORTEZOMIB

Last updated on 2020-10-22 History
Report ID 125031
Drug Identification Number 02438399
Brand name ACT BORTEZOMIB
Common or Proper name BORTEZOMIB 3.5MG PINJ
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) BORTEZOMIB
Strength(s) 3.5MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS
Packaging size 1
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-09-23
Estimated end date 2020-10-31
Actual end date 2020-10-21
Shortage status Resolved
Updated date 2020-10-22
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-10-22 French Compare
v3 2020-10-22 English Compare
v2 2020-09-25 French Compare
v1 2020-09-25 English Compare